Arai Y, Nishida M (2003) Differential diagnosis between normal endometrium and endometrial hyperplasia with immunostaining cytology using anti-LeY monoclonal antibody. Int J Gynecol Cancer 13:42–46

Article  CAS  PubMed  Google Scholar 

Arora S, Balasubramaniam S, Zhang W, Zhang L, Sridhara R, Spillman D, Mathai JP, Scott B, Golding SJ, Coory M, Pazdur R, Beaver JA (2020) FDA approval summary: pembrolizumab plus lenvatinib for endometrial carcinoma, a collaborative international review under project orbis. Clin Cancer Res 26:5062–5067

Article  CAS  PubMed  Google Scholar 

Baldus SE, Mönig SP, Zirbes TK, Thakran J, Köthe D, Köppel M, Hanisch FG, Thiele J, Schneider PM, Hölscher AH, Dienes HP (2006) Lewis(y) antigen (CD174) and apoptosis in gastric and colorectal carcinomas: correlations with clinical and prognostic parameters. Histol Histopathol 21:503–510

CAS  PubMed  Google Scholar 

Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10–17

Article  CAS  PubMed  Google Scholar 

Braun MM, Overbeek-Wager EA, Grumbo RJ (2016) Diagnosis and management of endometrial cancer. Am Fam Physician 93:468–474

PubMed  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

PubMed  Google Scholar 

Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Gonzalez Martin A, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O’Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, Creutzberg CL (2021) ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 31:12–39

Article  PubMed  Google Scholar 

Crucho CI, Correia-da-Silva P, Petrova KT, Barros MT (2015) Recent progress in the field of glycoconjugates. Carbohydr Res 402:124–132

Article  CAS  PubMed  Google Scholar 

Dall’Olio F (1996) Protein glycosylation in cancer biology: an overview. Clin Mol Pathol 49:M126–M135

Article  PubMed  PubMed Central  Google Scholar 

DeLisser HM, Christofidou-Solomidou M, Sun J, Nakada MT, Sullivan KE (1999) Loss of endothelial surface expression of E-selectin in a patient with recurrent infections. Blood 94:884–894

Article  CAS  PubMed  Google Scholar 

Engelstaedter V, Fluegel B, Kunze S, Mayr D, Friese K, Jeschke U, Bergauer F (2012) Expression of the carbohydrate tumour marker Sialyl Lewis A, Sialyl Lewis X, Lewis Y and Thomsen-Friedenreich antigen in normal squamous epithelium of the uterine cervix, cervical dysplasia and cervical cancer. Histol Histopathol 27:507–514

CAS  PubMed  Google Scholar 

Inoue M, Sasagawa T, Saito J, Shimizu H, Ueda G, Tanizawa O, Nakayama M (1987) Expression of blood group antigens A, B, H, Lewis-a, and Lewis-b in fetal, normal, and malignant tissues of the uterine endometrium. Cancer 60:2985–2993

Article  CAS  PubMed  Google Scholar 

Iwamori M, Tanaka K, Kubushiro K, Lin B, Kiguchi K, Ishiwata I, Tsukazaki K, Nozawa S (2005) Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the alpha1,2-fucosyltransferase gene. Cancer Sci 96:26–30

Article  CAS  PubMed  Google Scholar 

Iwanari O, Miyako J, Date Y, Nakayama S, Kijima S, Moriyama M, Karino K, Endoh J, Kitao M (1990) Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease. Gynecol Obstet Invest 29:214–218

Article  CAS  PubMed  Google Scholar 

Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K (2005) Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Anticancer Res 25:1615–1622

CAS  PubMed  Google Scholar 

Jin F, Wang F (2020) The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins. Glycoconj J 37:277–291

Article  CAS  PubMed  Google Scholar 

Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497:67–73

Article  PubMed  Google Scholar 

Kannagi R (2004) Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj J 20:353–364

Article  CAS  PubMed  Google Scholar 

Kannagi R (2007) Carbohydrate antigen sialyl Lewis a–its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J 30:189–209

PubMed  Google Scholar 

Kolben TM, Kraft F, Kolben T, Goess C, Semmlinger A, Dannecker C, Schmoeckel E, Mayr D, Sommer NN, Mahner S, Jeschke U (2017) Expression of Sialyl Lewis a, Sialyl Lewis x, Lewis y, Gal-3, Gal-7, STMN1 and p16 in cervical dysplasia. Future Oncol 13:145–157

Article  CAS  PubMed  Google Scholar 

Kommoss S, McConechy MK, Kommoss F, Leung S, Bunz A, Magrill J, Britton H, Kommoss F, Grevenkamp F, Karnezis A, Yang W, Lum A, Krämer B, Taran F, Staebler A, Lax S, Brucker SY, Huntsman DG, Gilks CB, McAlpine JN, Talhouk A (2018) Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. Ann Oncol 29:1180–1188

Article  CAS  PubMed  Google Scholar 

Lauc G, Vojta A, Zoldoš V (2014) Epigenetic regulation of glycosylation is the quantum mechanics of biology. Biochim Biophys Acta 1840:65–70

Article  CAS  PubMed  Google Scholar 

Legge F, Restaino S, Leone L, Carone V, Ronsini C, Di Fiore GLM, Pasciuto T, Pelligra S, Ciccarone F, Scambia G, Fanfani F (2020) Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment. Int J Gynecol Cancer 30:193–200

Article  PubMed  Google Scholar 

Lin Y, Pavenski K, Saidenberg E, Branch DR (2009) Blood group antigens and normal red blood cell physiology: a canadian blood services research and development symposium. Transfus Med Rev 23:292–309

Article  PubMed  Google Scholar 

Liu J, Lin B, Hao Y, Qi Y, Zhu L, Li F, Liu D, Cong J, Zhang S, Iwamori M (2009) Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway. J Exp Clin Cancer Res 28:154

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Zheng M, Qi Y, Wang H, Liu M, Liu Q, Lin B (2018) Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer. Int J Oncol 53:1774–1786

CAS  PubMed  Google Scholar 

Liu J, Liu Qi, Wang Y, Liu M, Qi Y, Gao J, Lin B (2019) Co-expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis. Int J Mol Med 43:1687–1698

CAS  PubMed  PubMed Central  Google Scholar 

Madjd Z, Parsons T, Watson NF, Spendlove I, Ellis I, Durrant LG (2005) High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Res 7:R780–R787

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moro-Rodríguez E, Álvarez-Fernández E (2008) Losses of expression of the antigens A, Lea and Lex and over-expression of Ley in carcinomas and HG-SIL of the uterine cervix. Diagn Pathol 3:38

Article  PubMed  PubMed Central  Google Scholar 

Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K, Ishikawa H (2002) Predictive factors for preoperative serum levels of sialy Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients. Anticancer Res 22:451–458

CAS  PubMed  Google Scholar 

Ohyama C, Kanto S, Kato K, Nakano O, Arai Y, Kato T, Chen S, Fukuda MN, Fukuda M (2002) Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides. Proc Natl Acad Sci U S A 99:13789–13794

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okuno K, Kawai I, Hirai N, Narimatsu H, Yasutomi M (2003) Role of sialyl Lewis X in liver metastasis in view of liver-associated immunity. Hepatogastroenterology 50:756–760

CAS  PubMed  Google Scholar 

Phillips ML, Nudelman E, Gaeta FC, Perez M, Singhal AK, Hakomori S, Paulson JC (1990) ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 250:1130–1132

Article  CAS  PubMed  Google Scholar 

Roseman S (2001) Reflections on glycobiology. J Biol Chem 276:41527–41542

Article  CAS  PubMed  Google Scholar 

Shah MH, Sainger RN, Telang SD, Pancholi GH, Shukla SN, Patel PS (2009) E-Cadherin truncation and sialyl Lewis-X overexpression in oral squamous cell carcinoma and oral precancerous conditions. Neoplasma 56:40–47

Article  CAS  PubMed  Google Scholar 

Society., American cancer. 2014. 'Cancer facts and figures', http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf. Accessed 27 Oct 2014

Taga M, Hoshino H, Low S, Imamura Y, Ito H, Yokoyama O, Kobayashi M (2015) A potential role for 6-sulfo sialyl Lewis X in metastasis of bladder urothelial carcinoma. Urol Oncol 33:496.e1–9

Article  CAS